Abstract CT140: NUC-3373, a targeted inhibitor of thymidylate synthase, in patients with advanced colorectal cancerFarasat Kazmi, TR Jeffry Evans, David J. Harrison et al.|Cancer Research|2021Cited by 2
Abstract C032: NUC-7738 in combination with pembrolizumab in patients with metastatic melanoma: Phase 2 results from the NuTide:701 studySarah P. Blagden, Elizabeth Ruth Plummer, Aglaia Skolariki et al.|Molecular Cancer Therapeutics|2023Cited by 1